EMBC News and Press, Embecta Corp. From 08/08/23

PARSIPPANY, N.J., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three- and nine-month periods ended June 30, 2023. "Having completed nearly a year and a...

2023-07-23 05:56:37 ET Summary Medical device company Embecta's share price has decreased by over 21% YTD in 2023, despite a growing market for diabetes solutions. Embecta has partnered with Tidepool to develop an automated insulin delivery system for type 2 diabetes, but clearanc...

2023-07-21 18:00:35 ET Summary Embecta Corp.'s stock has dropped 31% since its last publication, and analysis suggests this trend may continue. Despite securing key partnerships and signing multi-year agreements, projected revenue and earnings growth is flat. Net-net, reiterat...

2023-07-14 20:15:00 ET Summary The beginning of every month is exciting for all dividend income investors as we look back at the previous month and see how much passive dividend income our portfolios generated. Looking back at my June totals, I see that my year-over-year progress ...

PARSIPPANY, N.J., July 11, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, will host a conference call to discuss its fiscal third quarter 2023 financial results, provide an operational update, and host a question and answer session...

PARSIPPANY, N.J., May 15, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today announced that management will participate in the following investor conferences: 2023 RBC Capital Markets Gl...

PARSIPPANY, N.J., May 15, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today announced that management will participate in the following investor conferences: 2023 RBC Capital Markets Gl...

2023-05-12 10:47:07 ET Embecta Corp. (EMBC) Q2 2023 Earnings Conference Call May 12, 2023, 8:00 AM ET Company Participants Pravesh Khandelwal - Vice President, Investor Relations Dev Kurdikar - Chief Executive Officer Jake Elguicze - Chief Financial Officer ...

2023-05-12 06:39:48 ET Embecta press release ( NASDAQ: EMBC ): Q2 Non-GAAP EPS of $0.75 beats by $0.27 . Revenue of $277.1M (+0.9% Y/Y) beats by $14.22M . Adjusted EBITDA and margin of $96.7 million and 34.9%, compared to $117.3 million and 42.7% in the prior y...

2023-05-12 06:33:26 ET Embecta ( NASDAQ: EMBC ) is collaborating with Tidepool to develop an automated insulin delivery (AID) system for people with type 2 diabetes (T2D). Embecta said it will use the nonprofit organization Tidepool's expertise in diabetes management...